BCRB 2018

19/09/2018

Biological response modifiers Clinical

Karin Haustermans Department of Radiation Oncology, University Hospitals Leuven, Belgium

1

Overview

• Framework • Target driven lethality • EGFR inhibitors • Synthetic lethality • DNA-repair inhibitors • Contextual lethality • VEGF inhibitors

Chapter 20

Chapter 21 M Baumann & V Grégoire

• Vascular disrupting agents • Immune activation

• Take home messages

2

1